An Investigation of Growth Factors and Lactoferrin in Naturally Occurring Ovine Pulmonary Adenomatosis

Journal of Comparative Pathology

Volumn 147, Issue 4, 2012, Pages 441-451

  Sozmen, M ^a   Beytut, E ^b  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

^b KAFKAS UNIVERSITY   (Turkey)

Author keywords

Growth factors; Lung; Ovine pulmonary adenomatosis; Sheep

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; LACTOFERRIN; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR C; VASCULOTROPIN C;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY LABELING; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BODY FLUID; CYTOPLASM; EPITHELIUM CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INNATE IMMUNITY; JAAGSIEKTE; LUNG; LUNG ALVEOLUS CELL CARCINOMA; LUNG ALVEOLUS MACROPHAGE; NONHUMAN; PATHOGENESIS; PLASMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; FIBROBLAST GROWTH FACTOR 2; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LACTOFERRIN; LUNG NEOPLASMS; LYMPHOKINES; MACROPHAGES; PLASMA CELLS; PLATELET-DERIVED GROWTH FACTOR; PULMONARY ADENOMATOSIS, OVINE; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; SHEEP; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

BOVINAE; OVIS; OVIS ARIES;

EID: 84868617882     PISSN: 00219975     EISSN: 15323129     Source Type: Journal    
DOI: 10.1016/j.jcpa.2012.04.004     Document Type: Article

References (117)

1. Adams S.F., Hickson J.A., Hutto J.Y., Montag A.G., Lengyel E., et al. PDGFR-α as a potential therapeutic target in uterine sarcomas. Gynecologic Oncology 2007, 104:524-528.
2. Al-Dissi A.N., Haines D.M., Singh B., Kidney B.A. Immunohistochemical expression of vascular endothelial growth factor and vascular endothelial growth factor receptor associated with tumour cell proliferation in canine cutaneous squamous cell carcinomas and trichoepitheliomas. Veterinary Pathology 2007, 44:823-830.
3. Alitalo K., Tammela T., Petrova T.V. Lymphangiogenesis in development and human disease. Nature 2005, 14:946-953.
4. Alvarez R.H., Kantarjian H.M., Cortes J.E. Biology of platelet-derived growth factor and its involvement in disease. Mayo Clinical Proceedings 2006, 81:1241-1257.
5. Andrae J., Gallini R., Betsholtz C. Role of platelet-derived growth factors in physiology and medicine. Genes and Development 2008, 22:1276-1312.
6. Armistead P.M., Salganick J., Roh J.S., Steiner D.M., Patel S., et al. Expression of receptor tyrosine kinases and apoptotic molecules in rhabdomyosarcoma: correlation with overall survival in 105 patients. Cancer 2007, 110:2293-2303.
7. Asahara T., Bauters C., Zheng L.P., Takeshita S., Bunting S., et al. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation 1995, 92:365-371.
8. Bachelder R.E., Crago A., Chung J., Wendt M.A., Shaw L.M., et al. Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells. Cancer Research 2001, 61:5736-5740.
9. Barresi G., Tuccari G. Lactoferrin in benign hypertrophy and carcinomas of the parotid gland. Virchow's Archive (A) 1984, 394:61-73.
10. Barresi G., Tuccari G. Iron-binding proteins in thyroid tumours. An immunocytochemical study. Pathology Research and Practice 1987, 182:344-351.
11. Basilico C., Moscatelli D. The FGF family of growth factors and oncogenes. Advances in Cancer Research 1992, 59:115-166.
12. Battegay E.J., Thommen R., Humar R. Platelet derived growth factor and angiogenesis. Trends in Glycoscience and Glycotechnology 1996, 8:231-251.
13. Behrens C., Lin H.Y., Lee J.J., Raso M.G., Hong W.K., et al. Immunohistochemical expression of basic fibroblast growth factor and fibroblast growth factor receptors 1 and 2 in the pathogenesis of lung cancer. Clinical Cancer Research 2008, 14:6014-6020.
14. Benaissa M., Peyrat J.-P., Hornez L., Mariller C., Mazurier J., et al. Expression and prognostic value of lactoferrin mRNA isoforms in human breast cancer. International Journal of Cancer 2005, 114:299-306.
15. Bergers G., Benjamin L.E. Tumourigenesis and the angiogenic switch. Nature Reviews Cancer 2003, 3:401-410.
16. Beytut E., Sözmen M., Erginsoy S. Immunohistochemical detection of pulmonary surfactant proteins and retroviral antigens in the lungs of sheep with pulmonary adenomatosis. Journal of Comparative Pathology 2009, 140:43-53.
17. Bezault J., Bhimani R., Wiprovnick J., Furmanski P. Human lactoferrin inhibits growth of solid tumours and development of experimental metastases in mice. Cancer Research 1994, 54:2310-2312.
18. Birck A., Kirkin A.F., Zeuthen J., Hou-Jensen K. Expression of basic fibroblast growth factor and vascular endothelial growth factor in primary and metastatic melanoma from the same patients. Melanoma Research 1999, 9:375-381.
19. Brock J.H. The physiology of lactoferrin. Biochemical Cell Biology 2002, 80:1-6.
20. Cao R., Brakenhielm E., Li X., Pietras K., Widenfalk J., et al. Angiogenesis stimulated by PDGF-CC, a novel member in the PDGF family, involves activation of PDGFR-alphaalpha and -alphabeta receptors. FASEB Journal 2002, 16:1575-1583.
21. Capelozzi V.L. Role of immunohistochemistry in the diagnosis of lung cancer. Jornal Brasileiro de Pneumologia 2009, 35:375-382.
22. Chang L.K., Garcia-Cardena G., Farnebo F., Fornon M., Chen E.J., et al. Dose-dependent response of FGF-2 for lymphangiogenesis. Proceedings of the National Academy of Sciences USA 2004, 101:11658-11663.
23. Charpin C., Lachard A., Pourreau-Schneider N., Jacquemier J., Lavaut M.N., et al. Localization of lactoferrin and non-specific cross-reacting antigen in humanbreast carcinomas. An immunohistochemical study using the avidin-biotin-peroxidase complex. Cancer 1985, 55:2612-2617.
24. Cheung C.Y., Brace R.A. Ovine vascular endothelial growth factor: nucleotide sequence and expression in fetal tissues. Growth Factors 1998, 16:11-22.
25. Damiens E., Mazurier J., El Yazidi I., Masson M., Duthille I., et al. Effects of human lactoferrin on NK cell cytotoxicity against haematopoietic and epithelial tumour cells. Acta Biochimica et Biophysica 1998, 1402:277-287.
26. Damiens E., El Yazidi I., Mazurier J., Duthille I., Spik G., et al. Lactoferrin inhibits G1 cyclin-dependent kinases during growth arrest of human breast carcinoma cells. Journal of Cellular Biochemistry 1999, 74:486-498.
27. Dellacono F.R., Spiro J., Eisma R., Kreutzer D. Expression of basic fibroblast growth factor and its receptors by head and neck squamous carcinoma tumour and vascular endothelial cells. American Journal of Surgery 1997, 174:540-544.
28. De Marchis F., Ribatti D., Giampietri C., Lentini A., Faraone D., et al. Platelet-derived growth factor inhibits basic fibroblast growth factor angiogenic properties in vitro and in vivo through its α receptor. Blood 2002, 99:2045-2053.
29. Deng Z.-H., Cao H.-Q., Hu Y.-B., Wen J.-F., Zhou J.-H. TRX is up-regulated by fibroblast growth factor-2 in lung carcinoma. APMIS 2010, 119:57-65.
30. De Visser K.E., Eichten A., Coussens L.M. Paradoxical roles of the immune system during cancer development. Nature Reviews Cancer 2006, 6:24-37.
31. Dong J., Grunstein J., Tejada M., Peale F., Frantz G., et al. VEGF-null cells require PDGFR alpha signaling-mediated stromal fibroblast recruitment for tumourigenesis. EMBO Journal 2004, 23:2800-2810.
32. Donnem T., Al-Saad S., Al-Shibli K., Andersen S., Busund L.-T., et al. Prognostic impact of platelet-derived growth factors in non-small cell lung cancer tumour and stromal cells. Journal of Thoracic Oncology 2008, 3:963-970.
33. Du J.R., Jiang Y., Zhang Y.M., Fu H. Vascular endothelial growth factor and microvascular density in esophageal and gastric carcinomas. World Journal of Gastroenterology 2003, 9:1604-1606.
34. Feng Y., Wang W., Hu J., Ma J., Zhang Y., et al. Expression of VEGF-C and VEGF-D as significant markers for assessment of lymphangiogenesis and lymph node metastasis in non-small cell lung cancer. Anatomical Record 2010, 293:802-812.
35. Ferrara N., Kerbel R.S. Angiogenesis as a therapeutic target. Nature 2005, 438:967-974.
36. Folkman J. Clinical applications of research on angiogenesis. New England Journal of Medicine 1995, 333:1757-1763.
37. Fujita K., Ohnishi T., Sekine K., Iigo M., Tsuda H. Downregulation of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx)-induced CYP1A2 expression is associated with bovine lactoferrin inhibition of MeIQx-induced liver and colon carcinogenesis in rats. Japanese Journal of Cancer Research 2002, 93:616-625.
38. Gabler C., Lauer B., Einspanier A., Schams D., Einspanier R. Detection of mRNA and immunoreactive proteins for acidic and basic fibroblast growth factor and expression of the fibroblast growth factor receptors in the bovine oviduct. Journal of Reproduction and Fertility 1997, 109:213-221.
39. Gilbertson D.G., Duff M.E., West J.W., Kelly J.D., Sheppard P.O., et al. Platelet-derived growth factor C (PDGF-C), a novel growth factor that binds to PDGF alpha and beta receptor. Journal of Biological Chemistry 2001, 276:27406-27414.
40. Giuffre G., Barresi V., Skliros C., Barresi G., Tuccari G. Immunoexpression of lactoferrin in human sporadic renal cell carcinomas. Oncology Reports 2007, 17:1021-1026.
41. Goto F., Goto K., Weindel K., Folkman J. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. Laboratory Investigation 1993, 69:508-517.
42. Griffiths D.J., Martineau H.M., Cousens C. Pathology and pathogenesis of ovine pulmonary adenocarcinoma. Journal of Comparative Pathology 2010, 142:260-283.
43. Harbitz O., Jenssen A.O., Smidsrød O. Lysozyme and lactoferrin in sputum from patients with chronic obstructive lung disease. European Journal of Respiratory Diseases 1984, 65:512-520.
44. Heldin C.H., Eriksson U., Ostman A. New members of the platelet-derived growth factor family of mitogens. Archives of Biochemistry and Biophysics 2002, 398:284-290.
45. Hirota S., Ohashi A., Nishida T., Isozaki K., Kinoshita K., et al. Gain-of-function mutations of platelet-derived growth factor receptor α gene in gastrointestinal stromal tumours. Gastroenterology 2003, 125:660-667.
46. Hurley W.L., Rejman J.J. Bovine lactoferrin in involuting mammary tissue. Cell Biology International 1993, 17:283-289.
47. Iacopetta B.J., Morgan E.H., Yeoh G.C.T. Receptor-mediated endocytosis of transferrin by developing erythroid cells from the fetal rat liver. Journal of Histochemistry and Cytochemistry 1983, 31:336-344.
48. Inda A.M., Andrini L.B., Garcia M.N., Garcia A.L., Fernandez Blanco A., et al. Evaluation of angiogenesis with the expression of VEGF and CD34 in human non-small cell lung cancer. Journal of Experimental and Clinical Cancer Research 2007, 26:375-378.
49. Inoue M., Yamada J., Kitamura N., Shimazaki K., Andren A., et al. Immunohistochemical localization of lactoferrin in bovine exocrine glands. Tissue and Cell 1993, 25:791-797.
50. Ishida T., Kaneko S., Tateishi M., Oka T., Mitsudomi T., et al. Large cell carcinoma of the lung. Prognostic implications of histopathologic and immunohistochemical subtyping. American Journal of Clinical Pathology 1990, 93:176-182.
51. Javerzat S., Auguste P., Bikfalvi A. The role of fibroblast growth factors in vascular development. Trends in Molecular Medicine 2002, 8:483-489.
52. Joukov V., Pajusola K., Kaipainen A., Chilov D., Lahtinen I., et al. A novel endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO Journal 1996, 15:290-298.
53. Kanwar J.R., Palmano K.P., Sun X., Kanwar R.K., Gupta R., et al. 'Iron-saturated' lactoferrin is a potent natural adjuvant for augmenting cancer chemotherapy. Immunology and Cell Biology 2008, 86:277-288.
54. Kiriakidis S., Andreakos E., Monaco C., Foxwell B., Feldmann M., et al. VEGF expression in human macrophages is NF-κB-dependent: studies using adenoviruses expressing the endogenous NF-κB inhibitor IκBα and a kinase-defective form of the IκB kinase 2. Journal of Cell Science 2003, 116:665-674.
55. Kubo H., Cao R., Brakenhielm E., Makinen T., Cao Y., et al. Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea. Proceedings of the National Academy of Sciences USA 2002, 99:8868-8873.
56. Kubo T., Piperdi S., Rosenblum J., Antonescu C.R., Chen W., et al. Platelet-derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcoma. Cancer 2008, 112:2119-2129.
57. Leroux C., Girard N., Cottin V., Greenland T., Mornex J.F., et al. Jaagsiekte sheep retrovirus (JSRV): from virus to lung cancer in sheep. Veterinary Research 2007, 38:211-228.
58. Li X., Eriksson U. Novel PDGF family members: PDGF-C and PDGF-D. Cytokine Growth Factor Reviews 2003, 14:91-98.
59. Li D., Wang H., Xiang J.J., Deng N., Wang P.P., et al. Monoclonal antibodies targeting basic fibroblast growth factor inhibit the growth of B16 melanoma in vivo and in vitro. Oncology Reports 2010, 24:457-463.
60. 165- induced angiogenesis by competing heparin-like binding sites on endothelial cells. American Journal of Pathology 2006, 169:1753-1766.
61. Maiolino P., De Vico G., Restucci B. Expression of vascular endothelial growth factor in basal cell tumours and in squamous cell carcinomas of canine skin. Journal of Comparative Pathology 2000, 123:141-145.
62. Mandriota S.J., Jussila L., Jeltsch M., Compagni A., Baetens D., et al. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO Journal 2001, 20:672-682.
63. Martins-Green M., Boudreau N., Bissell M.J. Inflammation is responsible for the development of wound-induced tumours in chickens infected with Rous sarcoma virus. Cancer Research 1994, 54:4334-4341.
64. Matsuda Y., Saoo K., Hosokawa K., Yamakawa K., Yokohira M., et al. Post-initiation chemopreventive effects of dietary bovine lactoferrin on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumourigenesis in female A/J mice. Cancer Letters 2007, 246:41-46.
65. Millanta F., Caneschi V., Ressel L., Citi S., Poli A. Expression of vascular endothelial growth factor in canine inflammatory and non-inflammatory mammary carcinoma. Journal of Comparative Pathology 2010, 142:36-42.
66. Millanta F., Citi S., Della Santa D., Porciani M., Poli A. COX-2 expression in canine and feline invasive mammary carcinomas: correlation with clinicopathological features and prognostic molecular markers. Breast Cancer Research and Treatment 2006, 98:115-120.
67. Millanta F., Lazzeri G., Vannozzi I., Viacava P., Poli A. Correlation of vascular endothelial growth factor expression to overall survival in feline invasive mammary carcinomas. Veterinary Pathology 2002, 39:690-696.
68. Molenaar A.J., Davis S.R., Wilkins R.J. Expression of alpha-lactalbumin, alpha-S1-casein, and lactoferrin genes is heterogeneous in sheep and cattle mammary tissue. Journal of Histochemistry and Cytochemistry 1992, 40:611-618.
69. Muller A., Homey B., Soto H., Ge N., Catron D., et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001, 410:50-56.
70. Nieto A., Sanchez M.A., Martinez E., Rollan E. Immunohistochemical expression of p53, fibroblast growth factor-b, and transforming growth factor-α in feline vaccine-associated sarcomas. Veterinary Pathology 2003, 40:651-658.
71. Norrby K., Mattsby-Baltzer I., Innocenti M., Tuneberg S. Orally administered bovine lactoferrin systemically inhibits VEGF(165)-mediated angiogenesis in the rat. International Journal of Cancer 2001, 91:236-240.
72. Ostman A., Heldin C.H. PDGF receptors as targets in tumour treatment. Advances in Cancer Research 2007, 97:247-274.
73. Paavonen K., Horelli-Kuitunen N., Chilov D., Kukk E., Pennanen S., et al. Novel human vascular endothelial growth factor genes VEGF-B and VEGFC localize to chromosomes 11q13 and 4q34, respectively. Circulation 1996, 93:1079-1082.
74. Panella T.J., Liu Y.H., Huang A.T., Teng C.T. Polymorphism and altered methylation of the lactoferrin gene in normal leukocytes, leukemic-cells, and breast cancer. Cancer Research 1991, 51:3037-3043.
75. Pardo O.E., Wellbrock C., Khanzada U.K., Aubert M., Arozarena I., et al. FGF-2 protects small cell lung cancer cells from apoptosis through a complex involving PKCe{open}, B-RAF and S6K2. EMBO Journal 2006, 25:3078-3088.
76. Pinard C.L., Weiss M.L., Brightman A.H., Fenwick B.W., Davidson H.J. Evaluation of lysozyme and lactoferrin in lacrimal and other ocular glands of bison and cattle and in tears of bison. American Journal of Veterinary Research 2003, 64:104-108.
77. Platt J.A., Kraipowich N., Villafane F., DeMartini J.C. Alveolar type II cells expressing jaagsiekte sheep retrovirus capsid protein and surfactant proteins are the predominant neoplastic cell type in ovine pulmonary adenocarcinoma. Veterinary Pathology 2002, 39:341-352.
78. Ponten A., Li X., Thoren P., Aase K., Sjöblom T., et al. Transgenic overexpression of platelet-derived growth factor-C in the mouse heart induces cardiac fibrosis, hypertrophy, and dilated cardiomyopathy. American Journal of Pathology 2003, 163:673-682.
79. Presta M., Dell'Era P., Mitola S., Moroni E., Ronca R., et al. Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. Cytokine and Growth Factor Reviews 2005, 16:159-178.
80. Queiroga F.L., Pires I., Parente M., Gregorio H., Lopes C.S. COX-2 over-expression correlates with VEGF and tumour angiogenesis in canine mammary cancer. Veterinary Journal 2010, 189:77-82.
81. Qui C., Lin D.D., Wang H.H., Qiao C.H., Wang J., et al. Quantification of VEGF-C expression in canine mammary tumours. Australian Veterinary Journal 2008, 86:279-282.
82. Reigstad L.J., Varhaug J.E., Lillehaug J.R. Structural and functional specifities of PDGF-C and PDGF-D, the novel members of the platelet-derived growth factors family. FEBS Journal 2005, 272:5723-5741.
83. Ribatti D. The crucial role of vascular permeability factor/vascular endothelial growth factor in angiogenesis: a historical review. British Journal of Haematology 2005, 128:303-309.
84. Roiron D., Amouric M., Marvaldi J., Figarella C. Lactoferrin binding sites at the surface of HT29-D4 cells. European Journal of Biochemistry 1989, 186:367-373.
85. Samaniego F., Markham P.D., Gendelman R., Watanabe Y., Kao V., et al. Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development. American Journal of Pathology 1998, 152:1433-1443.
86. Sanchez L., Lujan L., Oria R., Castillo H., Perez D., et al. Synthesis of lactoferrin and transport of transferrin in the lactating mammary gland of sheep. Journal of Dairy Science 1992, 75:1257-1262.
87. Seto T., Higashiyama M., Funai H., Imamura F., Uematsu K., et al. Prognostic value of expression of vascular endothelial growth factor and its flt-1 and KDR receptors in stage I non-small-cell lung cancer. Lung Cancer 2006, 53:91-96.
88. Shaheduzzaman S., Vishwanath A., Furusato B., Cullen J., Chen Y., et al. Silencing of lactotransferrin expression by methylation in prostate cancer progression. Cancer Biology and Therapy 2007, 6:1088-1095.
89. Sharp J.M., DeMartini C. Natural history of JSRV in sheep. Current Topics in Microbiology and Immunology 2003, 275:55-79.
90. Shimamura M., Yamamoto Y., Ashino H., Oikawa T., Hazato T., et al. Bovine lactoferrin inhibits tumour-induced angiogenesis. International Journal of Cancer 2004, 10:111-116.
91. Shoji A., Ozawa E. Necessity of transferrin for RNA synthesis in chick myotubes. Journal of Cellular Physiology 1986, 127:349-356.
92. Siebert P.D., Huang B.C.B. Identification of an alternative form of human lactoferrin mRNA that is expressed differentially in normal tissues and tumour-derived cell lines. Proceedings of the National Academy of Sciences USA 1997, 94:2198-2203.
93. Stachowiak M.K., Maher P.A., Stachowiak E.K. Integrative nuclear signaling in cell development - a role for FGF receptor-1. DNA and Cell Biology 2007, 26:811-826.
94. Stacker S.A., Vitali A., Caesar C., Domagala T., Groenen L.C., et al. A mutant form of vascular endothelial growth factor (VEGF) that lacks VEGF receptor-2 activation retains the ability to induce vascular permeability. Journal of Biological Chemistry 1999, 274:34884-34892.
95. Stavri G.T., Zachary I.C., Baskerville P.A., Martin J.F., Erusalimsky J.D. Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells: synergistic interaction with hypoxia. Circulation 1995, 92:11-14.
96. Summers C., Norval M., De Las Heras M., Gonzalez L., Sharp J.M., et al. An influx of macrophages is the predominant local immune response in ovine pulmonary adenocarcinoma. Veterinary Immunology and Immunopathology 2005, 106:285-294.
97. Sun S., Schiller J.H., Gazdar A.F. Lung cancer in never smokers - a different disease. Nature Reviews Cancer 2007, 7:778-789.
98. Tavakoli K., Yu Y., Shahidi S., Bonar F., Walsh W.R., et al. Expression of growth factors in the mandibular distraction zone: a sheep study. British Journal of Plastic Surgery 1999, 52:434-439.
99. Tejada M.L., Yu L., Dong J., Jung K., Meng G., et al. Tumour-driven paracrine platelet-derived growth factor receptor α signaling is a key determinant of stromal cell recruitment in a model of human lung carcinoma. Clinical Cancer Research 2006, 12:2676-2685.
100. Teng C., Gladwell W., Raphiou I., Liu E. Methylation and expression of the lactoferrin gene in human tissues and cancer cells. BioMetals 2004, 17:317-323.
101. Tsuda H., Sekine K., Takasuka N., Toriyama-Baba H., Iigo M. Prevention of colon carcinogenesis and carcinoma metastasis by orally administered bovine lactoferrin in animals. Biofactors 2000, 12:83-88.
102. Tsutsumi N., Yonemitsu Y., Shikada Y., Onimaru M., Tanii M., et al. Essential role of PDGFRalpha-p70S6K signaling in mesenchymal cells during therapeutic and tumour angiogenesis in vivo: role of PDGFRalpha during angiogenesis. Circulation Research 2004, 94:1186-1194.
103. Tuccari G., Barresi G. Immunohistochemical demonstration of lactoferrin in follicular adenomas and thyroid carcinomas. Virchow's Archive (A) 1985, 406:67-74.
104. Tuccari G., Barresi G., Arena F., Inferrera C. Immunocytochemical detection of lactoferrin in human gastric carcinomas and adenomas. Archives of Pathology and Laboratory Medicine 1989, 113:912-916.
105. Tuccari G., Giuffrè G., Crisafulli C., Barresi G. Immunohistochemical detection of lactoferrin in human astrocytomas and multiforme glioblastomas. European Journal of Histochemistry 1999, 43:317-322.
106. Tuccari G., Giuffrè G., Scarfì R., Simone A., Todaro P., et al. Immunolocalization of lactoferrin in surgically resected pigmented skin lesions. European Journal of Histochemistry 2005, 49:33-38.
107. Tuccari G., Rossiello R., Barresi G. Iron binding proteins in gallbladder carcinomas. An immunocytochemical investigation. Histology and Histopathology 1997, 12:671-676.
108. Vogel H.J., Schibli D.J., Jing W., Lohmeier-Vogel E.M., Epand R.F., et al. Towards a structure-function analysis of bovine lactoferricin and related tryptophan- and arginine containing peptides. Biochemistry and Cell Biology 2002, 80:49-63.
109. Ward P.P., Uribe-Luna S., Conneely O.M. Lactoferrin and host defense. Biochemistry and Cell Biology 2002, 80:95-102.
110. Weinberg E.D. Iron withholding: a defense against infection and neoplasia. Physiological Reviews 1984, 64:65-102.
111. Westphal J.R., Van't Hullenaar R., Peek R., Willems R.W., Crickard K., et al. Angiogenic balance in human melanoma: expression of VEGF, bFGF, IL-8, PDGF and angiostatin in relation to vascular density of xenografts in vivo. International Journal of Cancer 2000, 86:768-776.
112. Yamada Y., Sato R., Kobayashi S., Hankanga C., Inanami O., et al. The antiproliferative effect of bovine lactoferrin on canine mammary gland tumour cells. Journal of Veterinary Medical Science 2007, 70:443-448.
113. Yang N., Stensen W., Svendsen J.S., Rekdal O. Enhanced antitumour activity and selectivity of lactoferrin-derived peptides. Journal of Peptide Research 2002, 60:187-197.
114. Yiangou C., Gomm J.J., Coope R.C., Law M., Luqmani Y.A., et al. Fibroblast growth factor 2 in breast cancer: occurrence and prognostic significance. British Journal of Cancer 1997, 75:28-33.
115. Yoshiji H., Gomez D.E., Shibuya M., Thorgeirsson U.P. Expression of vascular endothelial growth factor, its receptor, and other angiogenic factors in human breast cancer. Cancer Research 1996, 56:2013-2016.
116. Zhan P., Wang J., Lv X., Wang Q., Qiu L.X. Prognostic value of vascular endothelial growth factor expression in patients with lung cancer. Journal of Thoracic Oncology 2009, 4:1094-1103.
117. Zwerner J.P., May W.A. PDGF-C is an EWS/FLI induced transforming growth factor in Ewing family tumours. Oncogene 2001, 20:626-633.